4Rowe JM. Treatment of acute myelogenous leukemia in older adults. Leukemia,2000,14:480-487.
二级参考文献14
1[1]ZHANG ZN.The Criteria of Diagnosis and Curative Effect of Hematological Disease[M].Beijing:The Science Publishing Company,1998:279-285.
2[2]ROWE JM.Treatment of acute myelogenous leukemia in older adults[J].Leukemia,2000,14:480-487.
3[3]YAMADA K,FURUSAWA S,SAITO K,et al,Concurrent use of granulocyte colony-stimulating factor with with low-dose cytosine arabinoside and actarubian for previously treated acute myelogenous leukemia[J].A Pilot Study,Leukemia,1995,9(1):10-14.
4[4]LI JM,SHEN Y,WU DP,et al.Aclarabincin and low dose cytosine arabinoside in combination with granulocyte colony-stimulating factor in treating acute myeloid leukemia patients with relapsed or refractory disease and myelodysplastic syndrome:a multicenter study of 112 chinese patients[J].Int J Hematol,2005,82(1):48-54.
5[5]BAI A,KOJIMA H,HORI M,et al.Primary with G-CSF effectively enhances low-dose Ara-c-induced in vivo apoptosis in myeloid leukemia cells[J].Exp Hematol,1992,27(2):259-285.
6Buchner T, Hiddemann W, Berdel WE, et al. 6-thioguanine, cytarabine, and daunorubicin (TAD) and high-dose cytarabine and mitoxantrone (HAM) for induction,TAD for consolidation, and either prolonged maintenance by reduced monthly TAD or TAD-HAM-TAD and one course of intensive consolidation by sequential HAM in adult patients at all ages with de-novo acute myeloid leukemia(AML) .A randomized trial by the German AML Cooperative Group[J].J Clin Oncol, 2003,21:4496-4504.
7Mayer RJ, Davis RB, Schiffer CA, et al. Intensive postremission chemotherapy in adults with acute myeloid leukemia [J]. N Engl J Med, 1994,331:896-942.
8Weick JK, Kopecky KJ, Appelbaum FR, et al. A randomized investigation of high-dose versus standard-dose cytosine arabinoside with daunorubicin in patients with previously untreated acute myeloid leukemia: A Southwest Oncology Group Study [J]. Blood, 1996,88:2841-2851.
9Bishop JF, Matthews JP, Young GA, et al. Intensified induction chemotherapy with high dose cytarabine and etoposide for acute myeloid leukemia: A review and updated results from the Australian Leukemia Study Group [J]. Leuk Lymphoma, 1998,28:315-321.
10Kern W, Estey EH. High-dose cytosine arabinoside in the treatment of acute myeloid leukemia [J].Cancer, 2006,107: 116-124.
